BV-2711

N/A

Report date: 2025/01/26 16:15:58

Base Information

Drug NameBV-2711

Drug Alias NameT-STEALTH oncolytic virus (Janssen/BeneVir)oncolytic HSV-1 therapeutic (Janssen/BeneVir)Stealth-1Honcolytic HSV-1 (BeneVir)oncolytic HSV1 therapy expressing GM-CSF (BeneVir/Janssen) +[6]

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionImmunostimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumoursUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBenevir Biopharm Inc

China Registration ClassN/A

Develop Information

Active CompaniesJanssen Biotech Inc

Inactive CompaniesBenevir Biopharm Inc

Active IndicationsSolid tumoursUrinary Bladder Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A